Obstetrics & Gynecology Science

Gynecologic Oncology
Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma: Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat; Obstet Gynecol Sci. 2022;65(5):459-467. Published online July 29, 2022; DOI: https://doi.org/10.5468/ogs.22102; Full text PubReader ePub Crossref - TDM PDF

Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening: Kyung Nam Kang, Eun Young Koh, Ji Young Jang, Chul Woo Kim; Obstet Gynecol Sci. 2022;65(4):346-354. Published online April 21, 2022; DOI: https://doi.org/10.5468/ogs.22017; Full text PubReader ePub Crossref - TDM PDF

Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand: Wikanda Hemman, Athithan Rattanaburi; Obstet Gynecol Sci. 2022;65(2):188-196. Published online February 23, 2022; DOI: https://doi.org/10.5468/ogs.21313; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Maternal-Fetal Medicine
Ultrasonographic ovarian mass scoring system for predicting malignancy in pregnant women with ovarian mass: Se Jin Lee, Hye Rim Oh, Sunghun Na, Han Sung Hwang, Seung Mi Lee; Obstet Gynecol Sci. 2022;65(1):1-13. Published online December 14, 2021; DOI: https://doi.org/10.5468/ogs.21212
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Gynecologic Oncology
Prognostic significance of tumor laterality in advanced ovarian cancer: Yuki Yamada, Seiji Mabuchi, Naoki Kawahara, Ryuji Kawaguchi; Obstet Gynecol Sci. 2021;64(6):524-531. Published online September 14, 2021; DOI: https://doi.org/10.5468/ogs.21176
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer: Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi; Obstet Gynecol Sci. 2020;63(6):709-718. Published online September 17, 2020; DOI: https://doi.org/10.5468/ogs.20117
Cited By 3; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer: Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy; Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020; DOI: https://doi.org/10.5468/ogs.20033
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

Associations between metabolic syndrome and gynecologic cancer: Da Yong Lee, Taek Sang Lee; Obstet Gynecol Sci. 2020;63(3):215-224. Published online March 31, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.215
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis: Jinlan Piao, Hyun Ji Lim, Maria Lee; Obstet Gynecol Sci. 2020;63(3):346-356. Published online March 24, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.346
Cited By 5; Full text PubReader ePub Crossref - TDM PDF

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study: Semiramis L. Carbajal-Mamani, David Schweer, Merry J. Markham, Ashwini K. Esnakula, Joseph R. Grajo, Jacqueline C. Castagno, Joel Cardenas-Goicoechea; Obstet Gynecol Sci. 2020;63(2):150-157. Published online February 10, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.2.150
Cited By 6; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer: Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan; Obstet Gynecol Sci. 2020;63(1):64-71. Published online December 31, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.64
Cited By 10; Full text PubReader Crossref - TDM PDF

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy: Dhammapoj Jeerakornpassawat, Prapaporn Suprasert; Obstet Gynecol Sci. 2020;63(1):55-63. Published online December 23, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.55
Cited By 6; Full text PubReader Crossref - TDM PDF

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea: Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi; Obstet Gynecol Sci. 2019;62(6):411-419. Published online October 11, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.411
Cited By 3; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma: Joo-Hyuk Son, Seokyoung Yoon, Seokyung Kim, Tae-Wook Kong, Jiheum Paek, Suk-Joon Chang, Hee-Sug Ryu; Obstet Gynecol Sci. 2019;62(1):27-34. Published online December 3, 2018; DOI: https://doi.org/10.5468/ogs.2019.62.1.27
Cited By 5; Full text PubReader ePub Crossref - TDM PDF

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer: Wonkyo Shin, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim; Obstet Gynecol Sci. 2018;61(3):352-358. Published online May 9, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.3.352
Cited By 2; Full text PubReader Crossref - TDM PDF

Search